• Guest - w'd love to know what you think about the forum! Take the 2025 Survey »

IF this watch glucose tech is for real what happens to £50 Libre sensors

Well while I know I'm dreaming about it I think the fact that they are looking at this is a positive step. And why not as the numbers of type 2s increase it has to be a huge market right. I figure as I'm in my 50s maybe I will see it but even more hopefully (as my kids seem equally carbaholics) that it will make those in the future's life easier too.
 
You will also need a top of the line iPhone or Samsung Galaxy which could set you back ~$2000.00, this is on top of the watch price which could well be close to $1000.00 to be able to use it.

"Tell them they're dreaming.." as Darryl Kerrigan from The Castle would say.
 

i'd agree.

Not missing the point manufacturers may have spotted a couple of niche market
beyond "my phone does THIS..Does yours"..lol.

the reported issue of covid sufferers becoming diabetic..(pancreas attacked, i suspect causing issue)
AND Diabetes being one of the early markers attributed to covid complications/death
would have raised it's profile considerably

i'd say post lockdown we'll see a bigger take up in people wanting to halt any advance to T2D and avoiding pre diabtic levels
which would be a big market i'd suspect.
 
I believe there’s watch technology coming in the next few years that is closer to Libre/Dexcom, but the cost will be similar unfortunately. So the benefits will be ease of use, discrete, etc

E.g. https://www.pkvitality.com/ktrack-glucose/

I imagine Dexcom and Abbott are developing their own versions; so don’t be too concerned about their future profits
 
I remember watching a TV programme (may have been on the news) around the early 2000's, about a watch that you just look at and and it tells you your BG reading. At the time I liked the sound and when the CGM's came out I thought we are getting closer to what was suggested many years before.

We will just have to wait and see what comes!
 
I'd use it alongside finger prices - libre glue and i don't get on well
 
I believe the watches have to have a patch between the the pump and the skin to work, so it will not be cheap as the patches will need changing every few days, I may be wrong of course
 
Their biggest profit will come from those who pay willingly. Any profit from those provided for true medical reasons (ie on prescription) will be lower as they contract with large organisations (e.g NHS)
 
Peter03 said:
I believe the watches have to have a patch between the the pump and the skin to work, so it will not be cheap as the patches will need changing every few days, I may be wrong of course
Click to expand...
I believe the Apple and Samsung watches use some sort of spectroscopy, so no patches. Whether they work to a useful accuracy remains to be seen.
 
Apple Watch 7 is likely to have a version of CGM at launch and is currently undergoing reliability testing as well as stability field trials. This occurs before commercialisation.

Three years ago in 2018, a number of patents were applied for which were finally secured including body odour analysis and absorption spectroscopy to analyse materials in the blood. In-company trials have been on-going for 5 years as well as CIC technology partnerships for the same length of time.

However, those who want to use it as a clinical measurement device should realise that it will be bounded by indicative caveats at the outset as part of an overall fitness suite of apps. Using the feature to accurately determine insulin dosage for those reliant on this to manage their diabetes is not on the agenda and won't be for quite a while, if at all.

My current understanding is the initial positioning and use cases will be more lifestyle - so for example to help stem the tide of the T2 global epidemic by providing users of indicative elevated BG levels so they can potentially invoke their own diet/fitness regime changes.

As other posters have also said, local regulatory approvals will also have to be sought and secured before the app and related features can go live in specific geographies/markets.
 
@MrsA2 - Afternoon! In answer to your question regarding mutually exclusive ecosystems - work is currently underway between the 2 corporations to enable cross working between AAPL and GOOG entities focused on health care and NGO applications in the first instance. High level but not meandering aimlessly like some of the previous initiatives I've been involved with in the past.

As far as features are concerned ref CGM on AAPL wearables, I can't (not allowed to say), but some of the suggestions made here by posters are partially accurate, others way wide of the mark.

Clearly there's a market here with hundreds of millions of diabetics worldwide; as medtech is acquired and refined the ultimate aim is of course beyond initial capability...
 
It all sounds good and I hope it happens ! Will it be reliable and accurate enough only time will tell will you have to change it every so often when you can’t download the lastest software update . Almost defiently ., who knows maybe in time we’ll just use “ The Force”
 
Abbott is giving away 14day sensors. This might be a good time to give one a try.
 
Rachox said:
Just spotted this on Facebook:
https://www.macrumors.com/2021/05/2...oyj64J4L6KUqvclhBPw5cLKGQW9W6tZuhdw-V8_NYg0MY
All beginning to sound a lot more of a reality. I hope so
Click to expand...
I think this sentence from the article says it all: "The ability to observe any major increases or decreases in blood glucose on the Apple Watch may raise awareness of a potential health condition"
Sounds like it's meant to alert non-diabetic users of the watch if something strange is going on, not monitor the smaller changes we're looking for.
 
Yes I agree! It maybe ok for general trends but not accurate enough for insulin dosing
 
You must log in or register to reply here.
Menu
Log in
Register
Cookies are required to use this site. You must accept them to continue using the site. Learn More.…